The Vector Quality Index: Standardizing Multi-Ratio In-Process Controls

Start with what each assay measures

A useful quality dashboard begins with clear definitions. A capsid assay, a vector-genome measurement, and a functional transduction assay answer different analytical questions. A primary comparison of lentiviral titration methods showed that physical and functional measurements can diverge across vector preparations. [1]

Do not convert one result into another through an assumed universal factor. Retain the method, units, sample identity, and analytical limitations beside each result. That context is essential before any ratio is calculated.

Define ratios consistently

Our suggested dashboard separates the following views:

• TU/vg: functional transducing units relative to measured vector genomes.
• vg/TU: the reciprocal view, showing measured genomes relative to functional units.
• TU/ng p24: functional units relative to measured capsid mass.

Label the direction and units explicitly. A higher TU/vg and a lower vg/TU describe the same directional relationship when calculated from the same valid measurements. TU/ng p24 is a mass-based ratio, not a direct count of functional particles.

These ratios are summaries of assay results, not literal probabilities that an individual particle will transduce a cell. Avoid giving them a biological interpretation that the measurement methods cannot support.

Put measurement confidence before the score

Ratios can exaggerate uncertainty when one component is close to its reporting limit. Mark results as unavailable or not interpretable when the supporting measurement is outside its valid range. Never represent a missing value as zero.

Genome measurements also depend on the defined analytical method. A primary RT-ddPCR study addresses RNA-genome quantification and integrity assessment, illustrating why the assay target and preparation matter to the interpretation of a genome result. [2]

For this dashboard, retain control results, dilution history, sample handling, and method versions. A shift caused by changing the measurement system should not be presented as a confirmed shift in product quality.

Trend the components, not just a composite

We recommend displaying each original result alongside its ratios and the corresponding process stage. This lets reviewers identify whether a changing ratio reflects the numerator, the denominator, or both.

Keep material recovery separate from relative quality. A favorable ratio can coexist with low total recovery, so a single composite score may hide an important trade-off. If a team adopts a weighted index, document the formula, weighting rationale, intended use, and evidence supporting its interpretation.

The dashboard should also distinguish established historical observations from tentative alerts. Do not assign a universal good or bad threshold to a ratio without product-specific justification.

Use alerts to trigger review, not automatic conclusions

An unexpected trend is a prompt to review the underlying data. Check sample comparability and analytical validity, then describe what the available evidence can and cannot establish.

Document the review outcome and any unresolved questions. Keep this in-process dashboard separate from release decisions unless its role has been appropriately justified within the product's quality system. The benefit of a multi-ratio view is transparency: it makes disagreements between measurements visible instead of concealing them inside a single number.

References

1. Comparison of lentiviral vector titration methods.
2. Quantitation and integrity evaluation of RNA genome in lentiviral vectors by direct reverse transcription-droplet digital PCR (direct RT-ddPCR).